Phase II trial of neoadjuvant S-1 and concurrent radiotherapy for borderline resectable pancreatic cancer (JASPAC05)

被引：0

作者：

Ohno, Izumi ^{[1
]}

Takahashi, Shinichiro ^{[2
]}

Kobayashi, Tatsushi ^{[3
]}

Akimoto, Tetsuo ^{[4
]}

Toyama, Hirochika ^{[5
]}

Shimizu, Yasuhiro ^{[6
]}

Morinaga, Soichiro ^{[7
]}

Nakamori, Shoji ^{[8
]}

Hishinuma, Shoichi ^{[9
]}

Takakura, Norihisa ^{[10
]}

Takayama, Wataru ^{[11
]}

Hirano, Satoshi ^{[12
]}

Otsubo, Takehito ^{[13
]}

Ikeda, Masafumi ^{[1
]}

Uesaka, Katsuhiko ^{[14
]}

机构：

[1] Natl Canc Ctr East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan

[2] Natl Canc Ctr Hosp East, Dept Hepatobiliary Pancreat Surg, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr Hosp East, Dept Diagnost Radiol, Kashiwa, Chiba, Japan

[4] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan

[5] Kobe Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Kobe, Hyogo, Japan

[6] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan

[7] Kanagawa Canc Ctr, Dept Surg Gastroenterol, Yokohama, Kanagawa, Japan

[8] Natl Hosp Org Osaka Natl Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan

[9] Tochigi Canc Ctr, Dept Hepatobiliary Pancreat Surg, Utsunomiya, Tochigi, Japan

[10] Fukuyama City Hosp, Dept Surg, Fukuyama, Hiroshima, Japan

[11] Chiba Canc Ctr, Dept Hepatobiliary Pancreat Surg, Chiba, Japan

[12] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan

[13] St Marianna Univ, Sch Med Hosp, Dept Gastroenterol Surg, Kawasaki, Kanagawa, Japan

[14] Shizuoka Canc Ctr, Dept Hepatobiliary Pancreat Surg, Nagaizumi, Shizuoka, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O3 - 11 -

引用

页数：2

共 50 条

[1] Final results of JASPAC05: Phase II trial of neoadjuvant S-1 and concurrent radiotherapy followed by surgery in borderline resectable pancreatic cancer.
Takahashi, Shinichiro
Ohno, Izumi
Ikeda, Masafumi
Konishi, Masaru
Kobayashi, Tatsushi
Akimoto, Tetsuo
Kojima, Motohiro
Morinaga, Soichiro
Toyama, Hirochika
Shimizu, Yasuhiro
Miyamoto, Atsushi
Hishinuma, Shoichi
Takakura, Norihisa
Takayama, Wataru
Hirano, Satoshi
Otsubo, Takehito
Nagino, Masato
Kimura, Wataru
Sugimachi, Keishi
Uesaka, Katsuhiko
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer A Phase II Open-label Multicenter Prospective Trial (JASPAC05)
Takahashi, Shinichiro
Ohno, Izumi
Ikeda, Masafumi
Konishi, Masaru
Kobayashi, Tatsushi
Akimoto, Tetsuo
Kojima, Motohiro
Morinaga, Soichiro
Toyama, Hirochika
Shimizu, Yasuhiro
Miyamoto, Atsushi
Tomikawa, Moriaki
Takakura, Norihisa
Takayama, Wataru
Hirano, Satoshi
Otsubo, Takehito
Nagino, Masato
Kimura, Wataru
Sugimachi, Keishi
Uesaka, Katsuhiko
ANNALS OF SURGERY, 2022, 276 (05) : E510 - E517
[3] Phase II trial of neoadjuvant S-1 and concurrent radiotherapy for borderline resectable pancreatic cancer: Interim results of JASPAC05.
Takahashi, Shinichiro
Ohno, Izumi
Ikeda, Masafumi
Konishi, Masaru
Kobayashi, Tatsushi
Akimoto, Tetsuo
Kojima, Motohiro
Morinaga, Soichiro
Ku, Yonson
Shimizu, Yasuhiro
Nakamori, Shoji
Hishinuma, Shoichi
Takakura, Norihisa
Kainuma, Osamu
Hirano, Satoshi
Otsubo, Takehito
Nagino, Masato
Kimura, Wataru
Yamashita, Yoichi
Uesaka, Katsuhiko
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II trial (JASPAC05)
Takahashi, Shinichiro
Ohno, Izumi
Ikeda, Masafumi
Kobayashi, Tatsushi
Akimoto, Tetsuo
Kojima, Motohiro
Konishi, Masaru
Uesaka, Katsuhiko
BMJ OPEN, 2017, 7 (10):
[5] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Keiichi Okano
Hironobu Suto
Minoru Oshima
Eri Maeda
Naoki Yamamoto
Keitaro Kakinoki
Hideki Kamada
Tsutomu Masaki
Shigeo Takahashi
Toru Shibata
Yasuyuki Suzuki
Annals of Surgical Oncology, 2017, 24 : 2777 - 2784
[6] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Okano, Keiichi
Suto, Hironobu
Oshima, Minoru
Maeda, Eri
Yamamoto, Naoki
Kakinoki, Keitaro
Kamada, Hideki
Masaki, Tsutomu
Takahashi, Shigeo
Shibata, Toru
Suzuki, Yasuyuki
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2777 - 2784
[7] Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04)
Toyama, Hirochika
Sugiura, Teiichi
Fukutomi, Akira
Asakura, Hirofumi
Takeda, Yuriko
Yamamoto, Kouji
Hirano, Satoshi
Satoi, Sohei
Matsumoto, Ippei
Takahashi, Shinichiro
Morinaga, Soichiro
Yoshida, Makoto
Sakuma, Yasunaru
Iwamoto, Hidetaka
Shimizu, Yasuhiro
Uesaka, Katsuhiko
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[8] Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04)
Sugiura, Teiichi
Toyama, Hirochika
Fukutomi, Akira
Asakura, Hirofumi
Takeda, Yuriko
Yamamoto, Kouji
Hirano, Satoshi
Satoi, Sohei
Matsumoto, Ippei
Takahashi, Shinichiro
Morinaga, Soichiro
Yoshida, Makoto
Sakuma, Yasunaru
Iwamoto, Hidetaka
Shimizu, Yasuhiro
Uesaka, Katsuhiko
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (11) : 1249 - 1260
[9] Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer
Hattori, Masashi
Fujii, Tsutomu
Suenaga, Masaya
Yamada, Suguru
Kanda, Mitsuro
Iwata, Naoki
Kobayashi, Daisuke
Tanaka, Chie
Nakayama, Goro
Sugimoto, Hiroyuki
Koike, Masahiko
Nomoto, Shuji
Fujiwara, Michitaka
Kodera, Yasuhiro
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[10] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Thanikachalam, Kannan
Damarla, Vijay
Seixas, Trevor
Dobrosotskaya, Irina
Wollner, Ira
Kwon, David
Winters, Kenneth
Raoufi, Mohammad
Li, Jia
Siddiqui, Farzan
Khan, Gazala
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441

← 1 2 3 4 5 →